tiprankstipranks
Trending News
More News >

PYC Therapeutics Announces Cessation of Securities

Story Highlights
PYC Therapeutics Announces Cessation of Securities

Confident Investing Starts Here:

PYC Therapeutics Limited ( (AU:PYC) ) has provided an update.

PYC Therapeutics Limited announced the cessation of certain securities due to unmet conditions, affecting options expiring in 2026, 2027, and 2028. This announcement may impact the company’s capital structure and investor relations, as it reflects on the company’s strategic decisions regarding its financial instruments.

The most recent analyst rating on (AU:PYC) stock is a Buy with a A$4.00 price target. To see the full list of analyst forecasts on PYC Therapeutics Limited stock, see the AU:PYC Stock Forecast page.

More about PYC Therapeutics Limited

PYC Therapeutics Limited operates in the biotechnology industry, focusing on developing precision medicines. The company specializes in RNA therapeutics, targeting genetic disorders and diseases with unmet medical needs.

Average Trading Volume: 497,367

Technical Sentiment Signal: Buy

Current Market Cap: A$699.9M

For detailed information about PYC stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App